Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
1.020
+0.031 (3.18%)
Nov 22, 2024, 4:00 PM EST - Market closed
Rallybio Market Cap
Rallybio has a market cap or net worth of $42.32 million as of November 22, 2024. Its market cap has decreased by -67.46% in one year.
Market Cap
42.32M
Enterprise Value
-32.59M
1-Year Change
-67.46%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $42.32M, a decrease of -89.57%. That is a compound annual growth rate of -49.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 41.24M | -54.34% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 41.53M |
| Reviva Pharmaceuticals Holdings | 41.47M |
| Affimed | 41.40M |
| Gain Therapeutics | 41.37M |
| Nexalin Technology | 41.29M |
| iCAD, Inc. | 40.59M |
| DIH Holding US | 40.54M |
| Xilio Therapeutics | 40.44M |